hasubanan: originally isolated from Stephania japonica; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Stephania | genus | A plant genus of the family MENISPERMACEAE. Members contain cycleanine.[MeSH] | Asteraceae | A large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH] |
| Stephania | genus | A plant genus of the family MENISPERMACEAE. Members contain cycleanine.[MeSH] | Menispermaceae | A plant family of the order Ranunculales, subclass Magnoliidae, class Magnoliopsida. Members are mostly vines and shrubs and they contain isoquinoline alkaloids, some of which have been used as arrow poisons.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 6857499 |
| CHEBI ID | 35647 |
| SCHEMBL ID | 4756286 |
| MeSH ID | M000594943 |
| Synonym |
|---|
| hasubanan |
| CHEBI:35647 |
| 14510-67-9 |
| SCHEMBL4756286 |
| DTXSID60425891 |
| Q5680721 |
| (1r,10s)-17-azatetracyclo[8.4.3.01,10.02,7]heptadeca-2,4,6-triene |
| 3a,9b-butano-1h-benz(e)indole, 2,3,4,5-tetrahydro-, (3as-cis)- |
| unii-8k38rgp7sy |
| 8k38rgp7sy , |
| (3as-cis)-2,3,4,5-tetrahydro-3a,9b-butano-1h-benz(e)indole |
| Class | Description |
|---|---|
| isoquinoline alkaloid fundamental parent | |
| isoquinoline alkaloid | Any alkaloid that has a structure based on an isoquinoline nucleus. They are derived from the amino acids like tyrosine and phenylalanine. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.79) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||